Shilpa Medicare Profit & Loss Annual

Trade
BSE: 530549 | NSE: SHILPAMED | ISIN: INE790G01031 | Sector: Biotechnology & Drugs
901.70 -9.30 (-1.02%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,151.601,050.111,145.52901.13
Total Revenue 1,151.601,050.111,145.52901.13
Costof Revenue Total 407.55487.10449.39321.20
Gross Profit 744.05563.01696.14579.93
Selling/ General/ Admin Expenses Total 281.49406.32425.80352.74
Depreciation/ Amortization 107.8795.5079.8053.98
Unusual Expense( Income) -6.130.00-8.61-60.84
Other Operating Expenses Total 218.0619.0616.4721.09
Total Operating Expense 1,008.851,057.081,017.92721.98
Operating Income 142.76-6.96127.61179.15
Interest Inc( Exp) Net- Non- Op Total -965.88-451.81-357.30-98.85
Other Net 8.1714.1311.8126.37
Net Income Before Taxes 54.34-38.28102.26195.05
Provisionfor Income Taxes 22.39-7.3641.6848.85
Net Income After Taxes 31.96-30.9260.58146.20
Minority Interest -0.08-1.560.081.58
Net Income Before Extra Items 31.87-32.4860.66147.78
Net Income 31.87-32.4860.66147.78
Total Adjustmentsto Net Income 0.00---
Income Availableto Com Excl Extra Ord 31.87-32.4860.66147.78
Income Availableto Com Incl Extra Ord 31.87-32.4860.66147.78
Diluted Net Income 31.87-32.4860.66147.78
Diluted Weighted Average Shares 8.698.688.358.15
Diluted EPS Excluding Extra Ord Items 3.67-3.747.2618.13
Diluted Normalized EPS 3.25-3.726.7512.59
Research Development -491.02550.61338.09
Gain( Loss)on Saleof Assets --2.65-14.19-5.77
DPS- Common Stock Primary Issue -0.001.101.10
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts